Hansen Medical (HNSN) & Presbia (LENS) Critical Survey

Presbia (NASDAQ: LENS) and Hansen Medical (NASDAQ:HNSN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and profitability.

Analyst Ratings

This is a summary of recent ratings for Presbia and Hansen Medical, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Presbia 0 0 3 0 3.00
Hansen Medical 0 0 0 0 N/A

Presbia presently has a consensus price target of $9.67, suggesting a potential upside of 203.98%. Given Presbia’s higher probable upside, analysts plainly believe Presbia is more favorable than Hansen Medical.


This table compares Presbia and Hansen Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Presbia N/A -173.64% -137.41%
Hansen Medical -317.95% N/A -96.52%

Insider & Institutional Ownership

16.1% of Presbia shares are held by institutional investors. 74.7% of Presbia shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Presbia and Hansen Medical’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Presbia $10,000.00 5,444.16 -$15.75 million ($1.20) -2.65
Hansen Medical N/A N/A N/A ($31.62) -0.13

Hansen Medical has lower revenue, but higher earnings than Presbia. Presbia is trading at a lower price-to-earnings ratio than Hansen Medical, indicating that it is currently the more affordable of the two stocks.


Presbia beats Hansen Medical on 7 of the 10 factors compared between the two stocks.

About Presbia

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.

About Hansen Medical

Hansen Medical, Inc. is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter, CoHesion 3D Visualization Module and Magellan System. Its Sensei system allows physicians to navigate catheters in interventional procedures within the atrial heart chambers. Its disposable Artisan Extend catheter assembly consists of a telescoping set of control catheters. Its CoHesion 3D Visualization Module is a software interface between its Sensei system and the St. Jude Medical EnSite System for Electro-Physiology procedures. The Magellan System controls the Magellan Robotic Catheter, which is a telescoping, steerable catheter designed to facilitate remote catheter navigation and vessel cannulation.

Receive News & Ratings for Presbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply